RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 34-44
  • 9th Circuit bans juror exclusion over sexual orientation

    SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
  • Looking Out: Jurors can't be excluded based on sexual orientation, court says

    Looking Out: Jurors can't be excluded based on sexual orientation, court says
    In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations. Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
  • FDA affirms safety of diabetes drug Avandia, lifts restrictions on use

    FDA affirms safety of diabetes drug Avandia, lifts restrictions on use
    Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration. Federal regulators said Monday that the...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • GlaxoSmithKline launches probe into claims of misconduct in Iraq

    GlaxoSmithKline launches probe into claims of misconduct in Iraq
    British drug-maker GlaxoSmithKline said it is launching an investigation into claims of misconduct in Iraq. The announcement comes months after China began looking into allegations of a bribery ring within the company's business in that country. The...
  • A new era of testing [Commentary]

    A new era of testing [Commentary]
    Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits. The presence of these...
  • Televised confessions in China raise worries

    Televised confessions in China raise worries
    BEIJING — The headline news on state-run Chinese Channel 13 was juicy: A mining tycoon and 35 others had been charged with running a mafia-style enterprise in Sichuan province, gunning down enemies in the street, bribing people and operating an...
  • CVS' halt on tobacco wins praise

    CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...
  • Glaxo to stop paying doctors to promote its drugs

    Glaxo to stop paying doctors to promote its drugs
    Ending a practice that some say creates a conflict of interest, British pharmaceutical company GlaxoSmithKline said Tuesday it would end its practice of paying doctors to promote its drugs. Glaxo, maker of drugs such as the antidepressant Paxil, also...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Nuevo rival para el Viagra

    Nuevo rival para el Viagra
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...